Astrocytoma  >>  Caprelsa (vandetanib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caprelsa (vandetanib) / Sanofi
NCT00995007: A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Completed
2
112
US
ZD6474 (Vandetanib), Carboplatin
National Cancer Institute (NCI)
Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma
06/15
12/15
Zactima, NCT00441142: With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors

Checkmark P1/2 data
May 2011 - May 2011: P1/2 data
Completed
1/2
119
US
ZD6474, Vandetanib, Zactima, temozolomide, Temodar, Radiation Therapy, RT, XRT
Patrick Y. Wen, MD, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, University of Virginia, Memorial Sloan Kettering Cancer Center, Henry Ford Hospital
Glioblastoma Multiforme, Gliosarcoma
08/13
10/17

Download Options